Seelos Therapeutics Inc (SEELQ)
0.3001
-0.19
(-39.37%)
USD |
OTCM |
Nov 22, 16:00
Seelos Therapeutics Cash from Operations (Quarterly): -0.972M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.972M |
| March 31, 2024 | -4.642M |
| December 31, 2023 | -1.911M |
| September 30, 2023 | -5.749M |
| June 30, 2023 | -5.904M |
| March 31, 2023 | -10.35M |
| December 31, 2022 | -13.09M |
| September 30, 2022 | -11.07M |
| June 30, 2022 | -20.40M |
| March 31, 2022 | -17.04M |
| December 31, 2021 | -18.34M |
| September 30, 2021 | -10.51M |
| June 30, 2021 | -8.894M |
| March 31, 2021 | -11.25M |
| December 31, 2020 | -3.329M |
| September 30, 2020 | -4.18M |
| June 30, 2020 | -6.981M |
| March 31, 2020 | -6.423M |
| December 31, 2019 | -5.118M |
| September 30, 2019 | -2.91M |
| June 30, 2019 | -3.337M |
| March 31, 2019 | -7.94M |
| December 31, 2018 | -6.945M |
| September 30, 2018 | 2.684M |
| June 30, 2018 | -1.94M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.928M |
| December 31, 2017 | -2.473M |
| September 30, 2017 | -3.028M |
| June 30, 2017 | -2.269M |
| March 31, 2017 | -2.696M |
| December 31, 2016 | -2.705M |
| September 30, 2016 | -0.861M |
| June 30, 2016 | -3.237M |
| March 31, 2016 | -6.265M |
| December 31, 2015 | -1.31M |
| September 30, 2015 | -6.594M |
| June 30, 2015 | -8.611M |
| March 31, 2015 | -6.127M |
| December 31, 2014 | -9.118M |
| September 30, 2014 | -4.077M |
| June 30, 2014 | -4.628M |
| March 31, 2014 | -0.192M |
| December 31, 2013 | 1.007M |
| September 30, 2013 | -4.207M |
| June 30, 2013 | -5.093M |
| March 31, 2013 | -6.772M |
| December 31, 2012 | -2.735M |
| September 30, 2012 | -2.898M |
| June 30, 2012 | -3.589M |
| March 31, 2012 | -5.16M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.40M
Minimum
Jun 2022
-0.972M
Maximum
Jun 2024
-8.745M
Average
-6.981M
Median
Jun 2020
Cash from Operations (Quarterly) Benchmarks
| Cassava Sciences Inc | -18.30M |
| Bristol-Myers Squibb Co | 5.591B |
| enVVeno Medical Corp | -4.276M |
| 180 Life Sciences Corp | -0.2237M |
| NovaBay Pharmaceuticals Inc | -2.061M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.742M |
| Free Cash Flow | -13.27M |
| Free Cash Flow Per Share (Quarterly) | -6.183 |
| Free Cash Flow Yield | -50.32K% |